Restrictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients
Under a Creative Commons license
open archive
Key Words
Palivizumab
Respiratory syncytial virus
Bone marrow transplantation
Hematopoietic stem cell transplantation
Viral prophylaxis
Cited by (0)
Financial disclosure: See Acknowledgments on page 1906.
© 2016 American Society for Blood and Marrow Transplantation.